TH Open

Ausgabe 04 · Volume 04 · Oktober 2020 DOI: 10.1055/s-010-49819

Review Article

e288

Frydman, Galit H.; Streiff, Michael B.; Connors, Jean M.; Piazza, Gregory: The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents

e332

Pradhan, Akshyaya; Bhandari, Monika; Vishwakarma, Pravesh; Sethi, Rishi: Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Letter to the Editor

e300

Marongiu, Francesco; Barcellona, Doris: Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?

e351

Ding, Wern Yew; Lip, Gregory Y.H.; Fairbairn, Timothy; Binukrishnan, Sukumaran; Khalatbari, Afshin; Velavan, Periaswamy; Gupta, Dhiraj: Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion

e362

Traets, Marissa J.M.; Fischer, Kathelijn; Uitslager, Nanda; van der Valk, Paul R.; Kremer Hovinga, Idske C.L.; van Vulpen, Lize F.D.; Schutgens, Roger E.G.: Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc

Letter to the editor

e303

Golemi, Lolita; Hanson, Peter; Tafur, Alfonso: Frequently Asked Questions about Thrombosis during COVID-19 Pandemic

e318

Dubois, Marie Daniela; Pierre-Louis, Serge; Rabout, Johalène; Denis, Cécile V.; Christophe, Olivier; Susen, Sophie; Goudemand, Jenny; Boisseau, Pierre; Neviere, Rémi; Pierre-Louis, Olivier: A Combination of Two Variants p. (Val510 =) and p. (Pro2145Thrfs * 5), Responsible for von Willebrand Disease Type 3 in a Caribbean Patient

Case Report

e305

Sartori, Michelangelo; Cosmi, Benilde: Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia

Original Article

e309

Poh, Christina; Brunson, Ann; Keegan, Theresa; Wun, Ted; Mahajan, Anjlee: Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality

Supplementary Material

e322

Manderstedt, Eric; Lind-Halldén, Christina; Lethagen, Stefan; Halldén, Christer: Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients

Supplementary Material

e344

Coleman, Craig I.; Piazza, Gregory; Ashton, Veronica; Bunz, Thomas J.; Spyropoulos, Alex C.: Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis

e354

Takeyama, Masahiro; Nøhr, Anne Mette; Pollard, Debra: Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro

e365

Streng, Alexander S.; Delnoij, Thijs S.R.; Mulder, Mark M.G.; Sels, Jan Willem E.M.; Wetzels, Rick J.H.; Verhezen, Paul W.M.; Olie, Renske H.; Kooman, Jeroen P.; van Kuijk, Sander M.J.; Brandts, Lloyd; ten Cate, Hugo; Lorusso, Roberto; van der Horst, Iwan C.C.; van Bussel, Bas C.T.; Henskens, Yvonne M.C.: Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO

e376

Wenzler, Eric; Engineer, Monaz H.; Yaqoob, Maidah; Benken, Scott T.: Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease